IVD Medical Holding Limited

HKEX:1931.HK

1.8 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Revenue 1,711.0731,377.3141,572.2521,176.5571,543.8791,186.7911,446.97981.241,419.977912.763242.747170.888103.40984.56784.56784.56772.6172.6172.61
Cost of Revenue 1,340.9121,075.7741,230.534910.1341,217.5946.9021,164.984787.0611,131.007698.535170.619126.34574.24157.51457.51457.51451.63651.63651.636
Gross Profit 370.161301.54341.718266.423326.379239.889281.986194.179288.97214.22872.12844.54329.16827.05427.05427.05420.97520.97520.975
Gross Profit Ratio 0.2160.2190.2170.2260.2110.2020.1950.1980.2040.2350.2970.2610.2820.320.320.320.2890.2890.289
Reseach & Development Expenses 4.6084.0574.3642.8554.2493.0251.9181.5981.5411.1990.4320.2840.550.1490.1490.1490.0290.0290.029
General & Administrative Expenses 88.04771.93375.80277.408104.65879.19258.28785.80383.15741.51931.5523.1465.8172.3012.3012.3013.293.293.29
Selling & Marketing Expenses 75.74560.56871.2445.99976.29146.27765.76439.91662.61234.0086.425.2112.9082.5762.5762.5762.9212.9212.921
SG&A 162.926132.409149.133124.01180.482126.736120.264128.837146.53675.05138.92129.7418.7254.8774.8774.8776.2116.2116.211
Other Expenses 00000000000010.3369.2489.2489.2486.8396.8396.839
Operating Expenses 184.601129.641143.833151.911166.951112.71399.738122.827329.61126.884.0994.67319.6114.27414.27414.27413.07913.07913.079
Operating Income 207.235169.131192.585142.413145.897113.153161.72265.342142.434139.17733.2114.79930.38931.61531.61531.61516.31516.31516.315
Operating Income Ratio 0.1210.1230.1220.1210.0950.0950.1120.0670.10.1520.1370.0870.2940.3740.3740.3740.2250.2250.225
Total Other Income Expenses Net -30.815-6.222-12.291-38.9183.0855.8059.881-4.989-185.018200.34743.40726.206-0.9830.4650.4650.4650.20.20.2
Income Before Tax 176.42162.909180.294103.495148.982118.958171.60360.353-42.584339.52476.61741.00529.40632.0832.0832.0816.51516.51516.515
Income Before Tax Ratio 0.1030.1180.1150.0880.0960.10.1190.062-0.030.3720.3160.240.2840.3790.3790.3790.2270.2270.227
Income Tax Expense 43.29658.90754.46533.79464.59341.59753.07724.2611.73743.85812.2725.8424.5293.9313.9313.9312.2242.2242.224
Net Income 135.154103.009128.8581.14995.65478.887120.43738.281-23.502298.50367.32536.11524.87728.14928.14928.14914.29214.29214.292
Net Income Ratio 0.0790.0750.0820.0690.0620.0660.0830.039-0.0170.3270.2770.2110.2410.3330.3330.3330.1970.1970.197
EPS 0.10.0760.0950.060.0710.0590.090.029-0.040.310.110.0580.0190.0210.0210.0210.0110.0110.011
EPS Diluted 0.10.0760.0950.060.0710.0590.090.029-0.0180.310.110.0590.0190.0210.0210.0210.0110.0110.011
EBITDA 219.522180.812202.171155.371160.616125.556172.9177.135169.646149.15443.26622.48934.82535.27935.27935.27919.01619.01619.016
EBITDA Ratio 0.1280.1310.1290.1320.1040.1060.1190.0790.1190.1630.1780.1320.3370.4170.4170.4170.2620.2620.262